Correlation Between Jasper Therapeutics and MetaVia

Can any of the company-specific risk be diversified away by investing in both Jasper Therapeutics and MetaVia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jasper Therapeutics and MetaVia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jasper Therapeutics and MetaVia, you can compare the effects of market volatilities on Jasper Therapeutics and MetaVia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jasper Therapeutics with a short position of MetaVia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jasper Therapeutics and MetaVia.

Diversification Opportunities for Jasper Therapeutics and MetaVia

-0.55

Correlation Coefficient

Jasper Therapeutics  MetaVia

Excellent diversification

The 3 months correlation between Jasper and MetaVia is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Jasper Therapeutics and MetaVia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetaVia and Jasper Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jasper Therapeutics are associated (or correlated) with MetaVia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetaVia has no effect on the direction of Jasper Therapeutics i.e., Jasper Therapeutics and MetaVia go up and down completely randomly.

Pair Corralation between Jasper Therapeutics and MetaVia

Given the investment horizon of 90 days Jasper Therapeutics is expected to under-perform the MetaVia. But the stock apears to be less risky and, when comparing its historical volatility, Jasper Therapeutics is 4.23 times less risky than MetaVia. The stock trades about -0.14 of its potential returns per unit of risk. The MetaVia is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  71.00  in MetaVia on July 13, 2025 and sell it today you would earn a total of  27.00  from holding MetaVia or generate 38.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

Jasper Therapeutics  vs.  MetaVia

Jasper Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Jasper Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in November 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

MetaVia

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in MetaVia are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, MetaVia sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Jasper Therapeutics and MetaVia

The main advantage of trading using opposite Jasper Therapeutics and MetaVia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jasper Therapeutics position performs unexpectedly, MetaVia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetaVia will offset losses from the drop in MetaVia's long position.

The idea behind Jasper Therapeutics and MetaVia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.